Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09. (November 2019)
- Record Type:
- Journal Article
- Title:
- Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09. (November 2019)
- Main Title:
- Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
- Authors:
- Mishra, Mark V.
Khairnar, Rahul
Bentzen, Søren M.
Larson, Gary
Tsai, Henry
Sinesi, Christopher
Vargas, Carlos
Laramore, George
Rossi, Carl
Rosen, Lane
Zhu, Mingyao
Hartsell, William - Abstract:
- Highlights: Benefits of proton beam therapy for treatment of prostate cancer are unknown. Data comparing pencil beam vs. passive scatter/uniform scanning protons are limited. Significant differences in acute toxicity between proton modalities were observed. Future studies evaluating differences between the two proton modalities are needed. Abstract: Background and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using "conventional" PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those of PS/US in a prospective multicenter registry. Methods: We evaluated acute/late gastrointestinal (GI) and genitourinary (GU) toxicity rates for men with low-to-intermediate risk PC enrolled in PCG 001-09. Acute toxicities with the two techniques were compared using χ 2 tests, and the cumulative incidence methods for late toxicity. Multivariable analyses (MVAs) for acute toxicity were performed using logistic regression, and cox proportional hazards models for late toxicity. Results: Patients were treated using PS/US (n = 1105) or PBS (n = 238). Acute grade ≥2 GI toxicity in PBS did not significantly differ from that with PS/US (2.9% and 2.1%,Highlights: Benefits of proton beam therapy for treatment of prostate cancer are unknown. Data comparing pencil beam vs. passive scatter/uniform scanning protons are limited. Significant differences in acute toxicity between proton modalities were observed. Future studies evaluating differences between the two proton modalities are needed. Abstract: Background and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using "conventional" PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those of PS/US in a prospective multicenter registry. Methods: We evaluated acute/late gastrointestinal (GI) and genitourinary (GU) toxicity rates for men with low-to-intermediate risk PC enrolled in PCG 001-09. Acute toxicities with the two techniques were compared using χ 2 tests, and the cumulative incidence methods for late toxicity. Multivariable analyses (MVAs) for acute toxicity were performed using logistic regression, and cox proportional hazards models for late toxicity. Results: Patients were treated using PS/US (n = 1105) or PBS (n = 238). Acute grade ≥2 GI toxicity in PBS did not significantly differ from that with PS/US (2.9% and 2.1%, respectively; P = 0.47). Acute grade ≥2 GU toxicity was significantly higher with PBS (21.9% and 15.1%; P < 0.01). In MVA, PBS was significantly associated with increased acute grade ≥2 GU toxicity (RR = 1.57, p < 0.001). Late grade ≥2 GI and GU toxicities did not differ significantly between groups. Conclusions: This is the first multi-institutional comparative effectiveness evaluation of PBT techniques in PC. Differences in acute GU toxicity warrant further evaluation, and highlight the urgent need for prospective data using PBT. … (more)
- Is Part Of:
- Clinical and translational radiation oncology. Volume 19(2019)
- Journal:
- Clinical and translational radiation oncology
- Issue:
- Volume 19(2019)
- Issue Display:
- Volume 19, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 19
- Issue:
- 2019
- Issue Sort Value:
- 2019-0019-2019-0000
- Page Start:
- 80
- Page End:
- 86
- Publication Date:
- 2019-11
- Subjects:
- CTCAE Common Terminology Criteria for Adverse Events -- GI gastrointestinal -- GU genitourinary -- LET linear energy transfer -- MVA multivariable analysis -- PBT proton beam therapy -- PBS pencil beam scanning -- PC prostate cancer -- PCG Proton Collaborative Group -- PS/US passive scattering/uniform scanning -- RBE relative biological effectiveness -- RT radiation therapy -- PARTIQoL Prostate Advanced Radiation Technologies Investigating Quality of Life
Prostate cancer -- Proton therapy -- Pencil beam scanning -- Passive scattering, uniform scanning -- Comparative effectiveness, Toxicity
Cancer -- Radiotherapy -- Periodicals
Oncology -- Periodicals
Cancer -- Radiotherapy
Oncology
Radiation Oncology
Neoplasms -- radiotherapy
Translational Medical Research
Periodicals
Electronic journals
Periodicals
616.9940642 - Journal URLs:
- https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology ↗
http://www.sciencedirect.com/science/journal/24056308 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.ctro.2019.08.006 ↗
- Languages:
- English
- ISSNs:
- 2405-6308
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23178.xml